Infect volunteers with Covid-19 in the name of research? A proposal lays bare a minefield of issues
In 2016, a team of scientists asked the National Institutes of Health for permission to…
Category: Biotech
STAT Plus: What value? High prices for dozens of cancer drugs aren’t tied to better clinical benefits
As payers increasingly demand good value for medicines, a new analysis found that costs for…
Listen: Scott Gottlieb on Covid-19 treatments, reopening America, and going on TV every day
Just how well does Gilead Sciences’ Covid-19 drug work? Is politics getting in the way…
Doctors anticipate patient requests for experimental remdesivir before all the evidence comes in
Before Wednesday’s hopeful news about the experimental antiviral remdesivir broke, doctors treating patients hospitalized for…
Opinion: Suicides of two health care workers hint at the Covid-19 mental health crisis to come
The U.S. entered a grim new chapter in the coronavirus saga with the recent deaths…
STAT Plus: Covid-19 is forcing smaller biotechs to cut spending and change financing plans
The Covid-19 pandemic is taking a harsh toll on small biotech companies, many of which…
STAT Plus: Researchers develop a non-invasive way to manipulate neurons to study behavior
A version of this article first ran in Morning Rounds, STAT’s newsletter offering a daily…
Gilead’s remdesivir has seen success against the coronavirus. Now the company has to make enough to supply the world
In January, Gilead Sciences wasn’t manufacturing more than a few doses of its experimental antiviral…
Projecting Covid-19 death tolls is as difficult as ever. Comparing them to other causes of death is easier — and staggering
When STAT first compared projected U.S. deaths from Covid-19, in early April, there seemed to…
STAT Plus: Pharmalittle: U.S. plans ‘Operation Warp Speed’ for a Covid-19 vaccine; Gilead vows remdesivir will be accessible
Top of the morning to you. Despite some gloomy skies and a spot of rain,…
Mind-controlled prosthetic arm enables patients to feel the objects they grip
When electrician Rickard Normark lost his left arm after being electrocuted at work in 2011,…
Opinion: Are infertility treatments ‘essential’? How to ethically determine what kind of care must go on amid Covid-19
As the Covid-19 epidemic began to put an unprecedented strain on the U.S. health care…
Opinion: Cancer research offers faster ways to ID new Covid-19 treatments
As the Covid-19 pandemic unfolds across the globe, physicians are scrambling for treatments that can…
Opinion: Big Pharma could boost its reputation with a solid response to Covid-19
President Trump, a known critic of Big Pharma, summoned 10 executives from various pharmaceutical companies…
‘It doesn’t stay where you started’: Reopening some states heightens the risk of coronavirus surges in others
For all that’s still being discovered about the novel coronavirus, one thing was clear from…
Gilead CEO: We’re going to make sure that access is not an issue with remdesivir
On Wednesday Gilead Sciences, best known as a maker of HIV medicines, sent out a…
.jpg)
Diagnostics firm says new Covid-19 test could be used 1 million times a week
Hologic, a maker of diagnostic tests, said Wednesday that it is launching a new test…
STAT Plus: Watchdog scolds HHS for lacking a big-picture plan to incentivize antibiotic development
Amid growing anxiety over a lack of antibiotics, a new report from a Congressional watchdog…
NIH announces $1.5 billion, ‘Shark Tank’-like initiative to accelerate Covid-19 testing
WASHINGTON — The National Institutes of Health on Wednesday announced a new $1.5 billion initiative…
STAT Plus: Biogen’s blockbuster rare disease drug could be in trouble
The success of Biogen’s spinal muscular atrophy treatment Spinraza has been among the few bright…
A ‘sniff test’ signals consciousness after a brain injury, study shows
An unconscious person’s response to odors after a serious brain injury may be a simple…
Digital event: Combating Covid-19 — Part 2
Editor’s note: The live stream will be embedded below at 1 p.m ET. The pandemic…
STAT Plus: Pharmalittle: Pfizer says Covid-19 vaccine could be ready by fall for emergency use; an aggressive pitch to reopen the U.S.
Hello, everyone, and welcome to the middle of the week. Yes, we know, it can…
Gilead says critical study of Covid-19 drug shows patients are responding to treatment
A government-run study of Gilead’s remdesivir, perhaps the most closely watched experimental drug to treat…
Chan Zuckerberg Initiative funds Bay Area effort to track coronavirus as the economy reopens
A new research initiative backed by pediatrician Priscilla Chan and her husband, Facebook founder Mark…
Opinion: Primary care must be saved from being devastated by Covid-19
As the U.S. nears 60,000 deaths due to Covid-19, primary care could be among its…
Opinion: People with disabilities are at a disadvantage when scarce medical resources are being allocated
I have nightmares, whether I’m asleep or awake, as do many of us as we…
.jpg)
A bipartisan group of former health officials seeks to sell a $46.5 billion coronavirus plan to the White House
WASHINGTON — In the past month, President Trump’s senior adviser and son-in-law Jared Kushner has…
Opinion: We need the real CDC back, and we need it now
As political leaders discuss relaxing social distancing restrictions and opening up the economy again, a…
In fading steel towns, chronically ill patients hope video visits stay after the pandemic goes
Ordinarily Trueman Mills makes the trek to his cardiologist by car. He lives in rolling…
STAT Plus: Patients, drug makers grapple with how to continue cancer trials during the coronavirus
The coronavirus pandemic has thrown a wrench into plans for hundreds of clinical trials seeking…
How a Los Angeles doctor got swept up in the swirl of the Trump White House as it confronts the pandemic
He advised Joe Biden’s initiative to transform the fight against cancer. He interviewed Bill Clinton…
Hospital demand for hydroxycholoroquine to treat Covid-19 patients is waning
The ongoing uncertainty over whether hydroxycholoroquine can successfully treat Covid-19 appears to have eroded demand…
STAT Plus: For the first time, a blood test helped doctors find and treat cancers in seemingly healthy people
For the first time, doctors have used the results of a liquid biopsy test to…
STAT Plus: Off-the-shelf CAR-T therapy helps leukemia patients in a small, first-in-human trial
Scientists have created the first off-the-shelf CAR-T cells for a deadly form of adult leukemia,…
STAT Plus: Pharmalittle: Japan plans fast-track review of Gilead drug for Covid-19; most Americans think Trump whiffed on drug prices
Rise and shine, everyone, another busy and disorienting day is on the way. Although uncertainty…
STAT Plus: California fines more than a dozen drug makers for not providing drug pricing data
Over the past six months, California state authorities fined more than a dozen drug makers…
Opinion: The right words matter when talking about advance directives
We are being told to do a lot of things these days: Wash your hands….
Opinion: It’s time to make ClinicalTrials.gov a better tool for patients. Here’s how
Millions of people visit ClinicalTrials.gov each year to find a trial that they or a…
STAT Plus: China has near-total control of the world’s antibiotic supply. Is America at risk as a result?
WASHINGTON — The baby had so many pustules ravaging his face he could barely open…
Nursing ranks are filled with Filipino Americans. The pandemic is taking an outsized toll on them
Debbie Accad, 72, a clinical nursing coordinator for the Detroit VA Medical Center, died from…
STAT Plus: Most Americans believe Trump has failed to make progress lowering drug prices
More than one-third of U.S. adults believe that prescription drug prices have increased a lot…
Trump hopes for 2 million tests per week by end of May — the low end of experts’ estimates of what’s needed to reopen
WASHINGTON — The Trump administration on Monday unveiled a “blueprint” to increase capacity for coronavirus…
Opinion: Scientists who express different views on Covid-19 should be heard, not demonized
When major decisions must be made amid high scientific uncertainty, as is the case with…
STAT Plus: Vertex’s new cystic fibrosis drug needs to be far cheaper to be cost-effective, analysis finds
A newly approved treatment from Vertex Pharmaceuticals (VRTX) that targets roughly 90% of all cystic…
The world wants answers on Gilead’s Covid-19 drug. Experts worry next studies may increase uncertainty
For weeks, the world has been eagerly awaiting clinical trial results for one experimental drug,…
STAT Plus: ‘GI tract outside the body’ tests how well oral drugs are absorbed
When people swallow a pill, they expect the medicine to quickly reach the source of…
STAT Plus: Pharmalittle: Arthritis drug disappoints as a Covid-19 treatment; Pepcid is being tested to fight the coronavirus
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
Video Chat: A conversation on the coronavirus with Rich Besser
Editor’s note: The video recording will be embedded below at 11 a.m. ET. Rich Besser…
STAT Plus: Immunotherapy from Regeneron and Sanofi extends survival in non-small cell lung cancer
An immunotherapy from the drug firms Regeneron and Sanofi extended survival in previously untreated patients…